+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic BCG Vaccine Market by Application, Product Type, End User, Distribution Channel, Route of Administration - Global Forecast to 2030- Product Image
Therapeutic BCG Vaccine Market by Application, Product Type, End User, Distribution Channel, Route of Administration - Global Forecast to 2030- Product Image
Sale

Therapeutic BCG Vaccine Market by Application, Product Type, End User, Distribution Channel, Route of Administration - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986049
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The therapeutic BCG vaccine market is at a pivotal juncture, shaped by scientific innovation, regulatory changes, and evolving treatment paradigms in oncology and immunology. As the clinical landscape diversifies, decision-makers face critical choices in technology adoption, strategic collaborations, and supply chain management to sustain growth and competitive advantage.

Market Snapshot: Therapeutic BCG Vaccine Market

The Therapeutic BCG Vaccine Market grew from USD 60.31 million in 2024 to USD 63.17 million in 2025. It is expected to continue growing at a CAGR of 4.52%, reaching USD 78.66 million by 2030. This growth reflects expanding applications in oncology and emerging uses in autoimmune diseases, with rising adoption across global healthcare systems.

Scope & Segmentation

  • Therapeutic Applications: Bladder cancer (Carcinoma In Situ, Non-Muscle Invasive), Melanoma (Cutaneous, Mucosal), Type 1 diabetes (Adult, Pediatric)
  • Product Types: Danish Strain, Pasteur Strain, Tokyo Strain
  • End Users: Ambulatory surgical centers, Oncology clinics, Urology clinics, Hospitals
  • Distribution Channels: Hospital pharmacy, Online pharmacy, Retail pharmacy
  • Routes of Administration: Intradermal injection, Intravesical administration
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, Spain, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more)
  • Key Industry Players: Merck & Co., Inc., Sanofi S.A., Serum Institute of India Private Limited, Statens Serum Institut, Japan BCG Laboratory Co., Ltd., InterVax Inc., Laboratorios Reig Jofre S.A., Shanghai Institute of Biological Products Co., Ltd., Instituto Butantan, Jiangxi Institute of Biological Products Co., Ltd.

Key Takeaways: Market Trends and Strategic Insights

  • Expanding clinical use of therapeutic BCG vaccines has positioned them as a critical intervention in oncology, particularly for non-muscle invasive bladder cancer and trials in melanoma and Type 1 diabetes.
  • Ongoing innovation in strain selection and manufacturing, such as the adoption of closed-system bioreactors and advanced sterilization, is raising quality benchmarks and scaling production efficiently.
  • The integration of digital health technologies, including remote monitoring and telehealth platforms, is improving patient adherence and facilitating precise dosing schedules, especially for complex intravesical therapies.
  • Strategic collaborations between leading pharmaceutical firms, biotech companies, and contract development organizations are accelerating the co-development of novel combination regimens and optimizing resource utilization.
  • E-commerce is playing a growing role in maintenance-dose distribution, while hospital and retail pharmacies remain vital for initial therapy, signaling a shift in access channels and patient engagement models.
  • Segment distinctions—by product strain, therapeutic indication, and geography—are shaping competitive dynamics as stakeholders pursue targeted R&D and commercialization strategies.

Tariff Impact on Therapeutic BCG Vaccine Market

Recent U.S. tariffs imposed in 2025 have altered the cost structure for BCG vaccine production and logistics, driving up raw material and equipment expenses. Manufacturers are responding by diversifying sourcing, investing in process improvements, and considering alliances with contract producers in tariff-friendly regions. Larger, vertically integrated firms are positioned to weather these shifts, while smaller manufacturers may seek licensing arrangements or mergers to remain competitive.

Methodology & Data Sources

This analysis relies on comprehensive secondary research, targeted interviews with key stakeholders across academia, biotech, and manufacturing, and multi-round data validation. Proprietary databases, regulatory filings, and structured expert reviews ensure findings are accurate and actionable for strategic planning.

Why This Report Matters

  • Supports commercial planning by providing strategic segmentation, regional trends, and competitor profiles within the therapeutic BCG vaccine landscape.
  • Enables informed investment in technology, manufacturing, and distribution by highlighting process innovations, regulatory trends, and digital health integration.
  • Equips decision-makers to anticipate cost pressures and regulatory shifts, positioning organizations to sustain growth and patient impact.

Conclusion

The therapeutic BCG vaccine market presents evolving opportunities across oncology, immunology, and global health. Leaders that align innovation, operational efficiency, and targeted partnerships will be best equipped to adapt and succeed as the market transforms.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Therapeutic BCG Vaccine Market, by Application
8.1. Introduction
8.2. Bladder Cancer
8.2.1. Carcinoma In Situ
8.2.2. Non-Muscle Invasive
8.3. Melanoma
8.3.1. Cutaneous Melanoma
8.3.2. Mucosal Melanoma
8.4. Type 1 Diabetes
8.4.1. Adult
8.4.2. Pediatric
9. Therapeutic BCG Vaccine Market, by Product Type
9.1. Introduction
9.2. Danish Strain
9.3. Pasteur Strain
9.4. Tokyo Strain
10. Therapeutic BCG Vaccine Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.3.1. Oncology Clinics
10.3.2. Urology Clinics
10.4. Hospitals
11. Therapeutic BCG Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Therapeutic BCG Vaccine Market, by Route of Administration
12.1. Introduction
12.2. Intradermal Injection
12.3. Intravesical Administration
13. Americas Therapeutic BCG Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Therapeutic BCG Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Therapeutic BCG Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Sanofi S.A.
16.3.3. Serum Institute of India Private Limited
16.3.4. Statens Serum Institut
16.3.5. Japan BCG Laboratory Co., Ltd.
16.3.6. InterVax Inc.
16.3.7. Laboratorios Reig Jofre S.A.
16.3.8. Shanghai Institute of Biological Products Co., Ltd.
16.3.9. Instituto Butantan
16.3.10. Jiangxi Institute of Biological Products Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THERAPEUTIC BCG VACCINE MARKET MULTI-CURRENCY
FIGURE 2. THERAPEUTIC BCG VACCINE MARKET MULTI-LANGUAGE
FIGURE 3. THERAPEUTIC BCG VACCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. THERAPEUTIC BCG VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. THERAPEUTIC BCG VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THERAPEUTIC BCG VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CARCINOMA IN SITU, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY NON-MUSCLE INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CUTANEOUS MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MUCOSAL MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DANISH STRAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PASTEUR STRAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TOKYO STRAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY INTRAVESICAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 59. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 60. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 61. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 69. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 114. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 115. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 116. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 123. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 124. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 125. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 141. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 142. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 143. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 146. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 150. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 151. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 152. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 155. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 186. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 187. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 188. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 204. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 205. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 206. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 213. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 214. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 215. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 240. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 241. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 242. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 249. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 250. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 251. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 267. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 268. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 269. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 272. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 276. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 277. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 278. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 281. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 302. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 304. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 305. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 306. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 309. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 313. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 314. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 315. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2030 (USD MILLION)
TABLE 322. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
TABLE 323. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 324. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 327. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 329. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Therapeutic BCG Vaccine market report include:
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Serum Institute of India Private Limited
  • Statens Serum Institut
  • Japan BCG Laboratory Co., Ltd.
  • InterVax Inc.
  • Laboratorios Reig Jofre S.A.
  • Shanghai Institute of Biological Products Co., Ltd.
  • Instituto Butantan
  • Jiangxi Institute of Biological Products Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.17 Million
Forecasted Market Value ( USD ) by 2030 $ 78.66 Million
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Therapeutic BCG Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Therapeutic BCG Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Therapeutic BCG Vaccines Market Report 2025 - Product Image

Therapeutic BCG Vaccines Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Global BCG Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global BCG Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Bacillus Calmette-Guérin (BCG) Vaccines - Global Strategic Business Report - Product Image

Bacillus Calmette-Guérin (BCG) Vaccines - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology - Product Image

BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology

  • Report
  • 96 Pages
  • Global
From

About the BCG Vaccine Market

The BCG Vaccine is a vaccine used to protect against tuberculosis (TB). It is the only vaccine available for TB prevention and is used in many countries around the world. The BCG Vaccine market is a subset of the larger Vaccines market, which includes a wide range of vaccines used to prevent and treat various diseases. The BCG Vaccine market is largely driven by the prevalence of TB in different countries, as well as the availability of the vaccine. The BCG Vaccine market is highly competitive, with many companies offering the vaccine. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Serum Institute of India. Other companies in the market include Emergent BioSolutions, Bavarian Nordic, and Valneva. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.